Illinois Municipal Retirement Fund lowered its position in Danaher Corporation (NYSE:DHR - Free Report) by 22.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 18,146 shares of the conglomerate's stock after selling 5,395 shares during the quarter. Illinois Municipal Retirement Fund's holdings in Danaher were worth $3,720,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank purchased a new stake in Danaher during the fourth quarter valued at about $2,130,740,000. GAMMA Investing LLC increased its position in shares of Danaher by 24,958.2% during the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock valued at $383,524,000 after purchasing an additional 1,863,381 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Danaher during the 4th quarter valued at about $391,172,000. Two Sigma Advisers LP raised its holdings in shares of Danaher by 4,248.8% during the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after buying an additional 1,601,800 shares in the last quarter. Finally, Capital World Investors lifted its position in Danaher by 32.7% in the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after buying an additional 1,566,658 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Danaher Trading Up 0.4%
Danaher stock traded up $0.86 during trading on Wednesday, reaching $201.96. The company had a trading volume of 2,211,959 shares, compared to its average volume of 3,505,369. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The stock's 50 day moving average price is $195.27 and its two-hundred day moving average price is $207.84. The firm has a market capitalization of $144.54 billion, a price-to-earnings ratio of 39.32, a PEG ratio of 2.77 and a beta of 0.77.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. As a group, equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 24.85%.
Insider Buying and Selling at Danaher
In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president owned 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts have commented on DHR shares. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Guggenheim restated a "buy" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Finally, TD Cowen raised their price target on Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to MarketBeat, Danaher has an average rating of "Moderate Buy" and a consensus target price of $248.61.
View Our Latest Stock Report on Danaher
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report